Weight Loss · 3 min read
Tirzepatide vs Semaglutide: Which One Is Right for You?
Both are GLP-1s. Both produce major weight loss. But they aren't the same — here's how clinicians actually choose.
What's the same
Both tirzepatide and semaglutide are once-weekly injectable medications that work on the GLP-1 receptor system. Both reduce appetite, slow gastric emptying, and produce double-digit body-weight loss in clinical trials. Both are now compounded by partnered U.S. pharmacies and prescribed through telehealth at flat monthly pricing.
What's different
Tirzepatide is a dual GIP / GLP-1 agonist — it targets two metabolic receptors instead of one. In head-to-head trials (SURMOUNT-5), tirzepatide outperformed semaglutide on weight loss by roughly 47% (20.2% vs 13.7% body weight reduction at 72 weeks). Tirzepatide also tends to produce stronger glucose control.
How clinicians choose
Tirzepatide is generally the first choice for patients seeking the most aggressive weight-loss outcome. Semaglutide is preferred when (a) the patient has tolerated it well historically, (b) cost matters and semaglutide is meaningfully cheaper, or (c) the patient has specific cardiovascular indications semaglutide is studied for.
Side effect profile
Both share the same family of GI side effects: mild-to-moderate nausea, especially during dose titration. Tirzepatide can be slightly less GI-aggressive at equivalent weight-loss outcomes for some patients.
Bottom line
If maximum weight loss is the goal and cost isn't the deciding factor, tirzepatide. If you're price-sensitive or already have a relationship with semaglutide, semaglutide. Both are real medicine. Both work. Your BestRx clinician will help you pick.
Ready?
START YOUR ASSESSMENT
Four minutes. Clinician review within 24 hours. Plan shipped to your door.
Start NowRelated medications
